Mucosol 125 mg / 5 ml syrup for children 120 ml

Tradename:

Mucosol

Mucosol

Structure:

Each 5 ml of syrup contains:

Carbocisteine ​​125mg

Auxiliary components: methylparaben, propylparaben, sucrose, glycerin, sorbitol 70% solution, “Tutti-frutti” flavor, sodium hydroxide, purified water. Does not contain alcohol.

Properties:

Carbocisteine ​​(S-carboxymethyl L-cysteine) affects the nature and amount of mucus glycoprotein that is secreted by the respiratory tract. It is known that an increase in the acid: neutral glycoprotein ratio in mucus and the conversion of serous cells to mucus cells are the primary response to irritation and are usually accompanied by hypersecretion. Administration of carbocisteine ​​to stimulated animals indicates that the secreted glycoprotein remains normal; introduction after exposure indicates that the return to normal is accelerated. Human studies have shown that carbocisteine ​​reduces goblet cell hyperplasia. Consequently, carbocisteine ​​plays a role in the treatment of disorders characterized by abnormal mucus.

Indications:

As a mucolytic agent for the adjunctive therapy of respiratory diseases characterized by excessive or viscous mucus.

Mode of application:

Children from 2-5 years old: the usual dose is 2.5-5 ml 4 times a day. Children from 5-12 years old: the usual dose is 10 ml 3 times a day. Mucosol children’s syrup is intended for oral administration.

Contraindications:

Children under 2 years of age, hypersensitivity to the active substance or any of the excipients.

Precautions:

It is recommended to use with caution in elderly people who have a history of gastroduodenal ulcers, or those taking concomitant medications that cause gastrointestinal bleeding. If gastrointestinal bleeding occurs, patients should stop taking the medication. Patients with rare hereditary diseases of galactose intolerance, glucose-galactose malabsorption should not take Mucosol.

Side effects:

Immune system disorders: anaphylactic reactions. Gastrointestinal Disorders: Gastrointestinal bleeding that occurs during treatment with Mucosol. Frequency unknown: vomiting, gastrointestinal bleeding. Skin and subcutaneous tissue: skin rashes and other allergic skin rashes. Isolated cases of bullous dermatitis such as Stevens-Johnson syndrome and erythema multiforme have also been reported.

Pregnancy and lactation:

although tests in mammals have not revealed teratogenic effects, Mucosol is not recommended during the first trimester of pregnancy. There are not enough clinical studies during the breastfeeding period.

Storage:

Store at a temperature not exceeding 30C, out of reach of children.

Packaging:

The cardboard box contains a 120ml amber plastic bottle of syrup with an aluminum cap; and paper instructions.